Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Juan Collazo Jaloma"'
Autor:
Irma Olarte Carrillo, Anel Irais García Laguna, Adrián De la Cruz Rosas, Christian Omar Ramos Peñafiel, Juan Collazo Jaloma, Adolfo Martínez Tovar
Publikováno v:
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-9 (2021)
Abstract Background Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by different genetic alterations that cause changes in the normal mechanisms of differentiation, which are associated with chemoresistance. The A
Externí odkaz:
https://doaj.org/article/dec37ecaccbf4517accde4bc63604e0b
Autor:
Christian Ramos-Peñafiel, Irma Olarte-Carrillo, Rafael Cerón-Maldonado, Etta Rozen-Fuller, Juan Julio Kassack-Ipiña, Guillermo Meléndez-Mier, Juan Collazo-Jaloma, Adolfo Martínez-Tovar
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Abstract Background In acute lymphoblastic leukemia (ALL), high ABCB1 gene expression has been associated with treatment resistance, which affects patient prognosis. Many preclinical reports and retrospective population studies have shown an anti-can
Externí odkaz:
https://doaj.org/article/a5d05e3bd7cc48f1bbb0e8f6f4cfcd88
Autor:
Washington Ladines-Castro, Adrián Santoyo-Sánchez, Etta Rozen-Fuller, Irma Olarte-Carrillo, Adolfo Martínez-Tovar, Humberto Castellanos-Sinco, Juan Collazo-Jaloma, Christian Omar Ramos-Peñafiel
Publikováno v:
Duazary, Vol 13, Iss 2, Pp 142-148 (2016)
In order to establish the cutoff with prognostic implications for white blood cell count and age at diagnosis in adults with acute lymphoblastic leukemia (ALL), we conducted an observational, descriptive and analytical study nested in a retrospective
Externí odkaz:
https://doaj.org/article/97f3d8cf61d6475ca934c7230ef1706d
Autor:
Christian Omar Ramos-Peñafiel, Álvaro Cabrera-García, Etta Rozen-Fuller, Guadalupe González-León, Carolina Balderas, Juan Julio Kassack-Ipiña, Humberto Castellanos-Sinco, Carlos Martínez-Murillo, Efreen Montaño-Figueroa, Adolfo Martínez-Tovar, Irma Olarte-Carrillo, Adrián Santoyo-Sánchez, Juan Collazo-Jaloma
Publikováno v:
Revista Peruana de Medicina Experimental y Salud Pública, Vol 31, Iss 3 (2014)
In order to assess the mortality and toxicity of the Hyper-CVAD protocol used as first-line treatment of acute lymphoblastic leukemia, a retrospective cohort study was performed in patients less than 40 years of age from March to September 2011 treat
Externí odkaz:
https://doaj.org/article/1eb20b3f48b84896a191ab030b7ef6e3
Autor:
Christian Ramos-Peñafiel, Cristina Madera-Maldonado, Adrián Santoyo Sánchez, Erika Rojas-González, Irma Olarte-Carrillo, Adolfo Martínez-Tovar, Juan Collazo-Jaloma
Publikováno v:
Revista Colombiana de Cancerología. 25
El mieloma múltiple (MM) es una neoplasia originada de células B secundaria a diversas mutaciones post-germinales y cuya característica es el desarrollo de una clona de células plasmáticas que secretan un subtipo específico de inmunoglobulina c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdddefdcd98b9dc422b70c37a26e965d
https://doi.org/10.35509/01239015.140
https://doi.org/10.35509/01239015.140
Autor:
Adolfo Martínez Tovar, Anel Irais García Laguna, Juan Collazo Jaloma, Irma Olarte Carrillo, Adrián de la Cruz Rosas, Christian Omar Ramos Peñafiel
Publikováno v:
BMC Medical Genomics
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-9 (2021)
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-9 (2021)
Background Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by different genetic alterations that cause changes in the normal mechanisms of differentiation, which are associated with chemoresistance. The ABCB1 gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e28fc016d3e778c3221d4c5aead45d33
https://pubmed.ncbi.nlm.nih.gov/34702282
https://pubmed.ncbi.nlm.nih.gov/34702282
Autor:
Juan Collazo-Jaloma, Adrián de la Cruz Rosas, Christian Omar Ramos-Peñafiel, Irma Olarte-Carrillo, Rafael Cerón Maldonado, Adolfo Martínez-Tovar
Publikováno v:
Annals of hematology. 99(11)
Treatment of acute lymphoblastic leukemia (ALL) requires the combination of multiple drugs to integrate a complete remission. The different prognostic factors (age, leukocytes, risk, cytogenetic alterations) allow identifying those patients with a hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52bcccd1d02476e791fa96fc8c4d2102
https://pubmed.ncbi.nlm.nih.gov/32980890
https://pubmed.ncbi.nlm.nih.gov/32980890
Autor:
Federico Centeno Cruz, Rafael Cerón Maldonado, Enrique Miranda Peralta, Etta Rozen Fuller, Irma Olarte Carrillo, Christian Omar Ramos Peñafiel, Juan Collazo Jaloma, Adolfo Martínez Tovar, Juan Julio Kassack Ipiña
Publikováno v:
Revista médica de Chile v.146 n.7 2018
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Metformin has antineoplastic and cancer protective effects in vitro, sensitizing leukemia cells to chemotherapeutic agents, inducing apoptosis and cell cycle arrest. Aim: To assess the effect of metformin on the induction stage in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93920f5513ef7aca157107a558c2bb74
https://doi.org/10.4067/s0034-98872018000700846
https://doi.org/10.4067/s0034-98872018000700846
Autor:
Christian Omar Ramos-Peñafiel, A. García-Laguna, Irma Olarte-Carrillo, A. De la Cruz-Rosas, Adolfo Martínez-Tovar, Juan Collazo-Jaloma, R. Cerón-Maldonado, Enrique Miranda-Peralta, I. Mendoza-Salas
Publikováno v:
Revista Médica del Hospital General de México, Vol 81, Iss 2, Pp 86-92 (2018)
Multiple myeloma is the most common form of plasma cell cancer. It is a disease of elderly people, with a mean age at diagnosis of 65–70, and represents 10–15% of all blood cancers. It is a heterogeneous disease associated with intrinsic factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec35394cd5eb1d8f7d0cd046709f5dc3
http://www.sciencedirect.com/science/article/pii/S0185106316300701
http://www.sciencedirect.com/science/article/pii/S0185106316300701
Autor:
Christian Omar Ramos-Peñafiel, Guadalupe León-González, Juan Collazo-Jaloma, Silvia Cabrera-Ozuna, Humberto Castellanos-Sinco, Adolfo Martínez-Tovar, Adrián Santoyo-Sánchez, Efreen Horacio Montaño-Figueroa, Irma Olarte-Carrillo
Publikováno v:
Revista Colombiana de Cancerología. 20:159-166
Resumen Objetivos Identificar aquellos factores que impactan en la respuesta terapeutica para alcanzar una segunda remision (2 RC) en pacientes con leucemia aguda linfoblastica (LAL) en recaida. Metodos Estudio observacional y analitico anidado en un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf68acbcbf213b6f00a252849a659c8d
https://doi.org/10.1016/j.rccan.2016.11.001
https://doi.org/10.1016/j.rccan.2016.11.001